APA (7th ed.) Citation

X, W., L, W., Y, Q., B, Z., Z, H., & R, J. (2018). Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum]. Dove Medical Press.

Chicago Style (17th ed.) Citation

X, Wu, Wang L, Qiu Y, Zhang B, Hu Z, and Jin R. Cooperation of IRAK1/4 Inhibitor and ABT-737 in Nanoparticles for Synergistic Therapy of T Cell Acute Lymphoblastic Leukemia [Corrigendum]. Dove Medical Press, 2018.

MLA (8th ed.) Citation

X, Wu, et al. Cooperation of IRAK1/4 Inhibitor and ABT-737 in Nanoparticles for Synergistic Therapy of T Cell Acute Lymphoblastic Leukemia [Corrigendum]. Dove Medical Press, 2018.